GLOBAL LIFE SCIENCE VENTURES

Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance, advice and access to expertise and networks. The group advised and managed funds totaling more than โฌ 200 million. With offices in Germany and Switzerla... nd, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.
GLOBAL LIFE SCIENCE VENTURES
Industry:
Financial Services Life Science Venture Capital
Founded:
1996-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Apache Euro 1and1 Symantec.cloud Thomson Reuters Corporate Solutions
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2017-01-23 | Binx Health | Global Life Science Ventures investment in Series D - Binx Health | 35 M USD |
2015-01-29 | Binx Health | Global Life Science Ventures investment in Series C - Binx Health | 20 M USD |
2012-06-21 | Santaris Pharma | Global Life Science Ventures investment in Venture Round - Santaris Pharma | 12 M USD |
2010-07-16 | Action Pharma | Global Life Science Ventures investment in Series C - Action Pharma | 6.3 M USD |
2009-12-29 | Coapt Systems | Global Life Science Ventures investment in Debt Financing - Coapt Systems | 3.72 M USD |
2009-09-23 | Agendia | Global Life Science Ventures investment in Series E - Agendia | 23 M USD |
2007-12-30 | Santaris Pharma | Global Life Science Ventures investment in Series C - Santaris Pharma | 20.4 M EUR |
2007-08-28 | Agendia | Global Life Science Ventures investment in Series D - Agendia | 34 M USD |
2007-03-29 | Coapt Systems | Global Life Science Ventures investment in Series E - Coapt Systems | 22.6 M USD |
2007-03-29 | Nitec Pharma AG | Global Life Science Ventures investment in Series B - Nitec Pharma AG | 26 M USD |
More informations about "Global Life Science Ventures"
GLSV - Global Life Science Ventures
Jun 11, 2013 Global Life Science Ventures (GLSV) was a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in โฆSee details»
Global Life Science Ventures - Crunchbase
Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund โฆSee details»
Global Life Science Ventures - Investments, Portfolio & Company โฆ
Global Life Science Ventures has made 2 diversity investments. Their most recent diversity investment was on Dec 1, 2005, when NeurogesX raised. obfuscated. obfuscated. Announced โฆSee details»
Global Life Science Ventures | Qodeo
Raising the Fund, Deploying into New & Portfolio Companies, Exiting my Portfolio, Secondary Sale of Fund and End of Fund Life Total Number Inbound Per Annum 561See details»
Global Life Science Ventures - Contacts, Employees, Board โฆ
Global Life Science Ventures has 4 current employee profiles, including Chief Executive Officer Brad Van Pelt. Brad Van Pelt Chief Executive Officer. Peter Reinisch Partner. Hans Kupper โฆSee details»
Global Life Science Ventures GmbH | Institution Profile | Private ...
Global Life Science Ventures GmbH News, insights, analysis and data Founded in 1996, Global Life Science Ventures GmbH was a Germany-based private equity firm that targeted early โฆSee details»
Global Life Science Ventures investment portfolio - PitchBook
Jun 20, 2012 Global Life Science Ventures's latest investment was on 07-Apr-2015 in Nabriva Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our โฆSee details»
Global Life Science Ventures โ Investing in the life sciences
Global Life Science Ventures (GLSV) was a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, โฆSee details»
Global Life Science Ventures โ Investing in the life sciences
Oxford Bioscience Partners is a life science venture capital firm that provides equity financing and management assistance to start-up and early-stage, entrepreneurial-driven companies in the โฆSee details»
Life Science Ventures GmbH - Life-Sciences-Europe.com
Jan 1, 1998 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl โ the European Association of Bioindustries; BioIndustry โฆSee details»
Life Science Ventures โ Life Science Ventures
Life Science Ventures, Inc., (LSV) is a management company headquartered in Indianapolis. We are focused on building innovative business models and strategic partnerships that drive profitable growth and performance โฆSee details»
Home - LifeX
Ventures. About LifeX Ventures Providing tailored financing solutions & global team resources to help build world-class healthcare companies. Portfolio Our founder-first philosophy has โฆSee details»
Top 80 Life Sciences Venture Capital Firms in 2024 - Failory
Lightstone Ventures is a life science early-stage venture capital firm. Details of the VC firm: Country: USA, Ireland, Singapore ... OneVentures is a renowned VC organization in Australia, โฆSee details»
2025 life sciences outlook | Deloitte Insights
While several potentially disruptive forces could reshape the life sciences industry in 2025, the vast majority (75%) of global life sciences executives are optimistic about the year ahead, โฆSee details»
Global Life Science Ventures - Tech Stack, Apps, Patents
Global Life Science Ventures is a swiss investment fund focusing exclusively on the life sciences sector.See details»
Life science ecosystems in Asia: biomedical innovation trends
6 days ago The United States and Europe have long been centres of biomedical innovation, accounting for ~90% of all new molecular entities (NMEs) approved between 1990โ2014 โฆSee details»
2025 KPMG Healthcare and Life Sciences Investment Outlook
Jan 13, 2025 NEW YORK โ Anticipating high valuations and intense competition for limited high-value assets, healthcare and life science (HCLS) investors remain the most bullish they have โฆSee details»
Inside the futuristic biotech startup Cellares thatโs building a cure ...
3 days ago Inside the futuristic biotech startup Cellares thatโs building a cure for cancer with $355 million in fundingSee details»
Flagship startup raises $200M in pursuit of โscientific ...
Mar 12, 2025 Artificial intelligenceโs promise to accelerate life sciences research has already drawn billions of dollars of investment in recent years, fueling the rise of companies like โฆSee details»
Simplification for success: Rewiring the biopharma operating model
6 days ago These signals are also reflected in the results of our recent survey of 50 global life sciences leaders. 2 McKinsey Global Life Science Leaders Simplification Survey, November โฆSee details»